Latest news
When Dementia Takes Speech, Trials Must Catch Up
CervoMed has completed enrolment in a Phase IIa study of neflamapimod in nonfluent/agrammatic primary progressive aphasia. The milestone is small, but the unmet need is not.
Metastatic Cancer Means Living With Loss Before the End
Surviving Cancer Is Not the Same as Being Recovered
Tourette Care May Finally Get a New FDA Test
Dementia Is Not the End of Personhood
Hantavirus Quarantine Turns Travel Health Into a Civil-Liberties Test
mRNA Flu Shots Are No Longer a Pandemic Experiment
IPM Brief – Issue 4 | Who Carries the Risk?
MRD Testing Moves From Prognosis Toward Treatment Action
Colon Cancer Immunotherapy Moves Into the Adjuvant Access Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.